Nutrition and Neurological Development of Very Preterm Infants
EPINUTRI_3
Early Nutrition and Neurological Development of Very Preterm Infants
2 other identifiers
observational
206
1 country
1
Brief Summary
The main goal of this study is to determine, in preterm infants born with a GA \< 32 weeks, the association between:
- the quantity of mother's milk and duration and breastfeeding
- the intake of polyunsaturated fatty acids and iron during hospitalizations
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2014
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 3, 2014
CompletedFirst Posted
Study publicly available on registry
July 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2017
CompletedNovember 20, 2025
September 1, 2025
1 year
July 3, 2014
November 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Neurological development
Age and Stages Questionnaire
At 3 years of age
Study Arms (1)
Premature infants
Premature infants with a GA \< 32 weeks
Interventions
At 3 years of age: ASQ (filled in by parents)
Eligibility Criteria
Subsample of infants born very preterm (before 32 weeks of gestation), otherwise included in the French national cohort EPIPAGE 2, and previously included in EPINUTRI study.
You may qualify if:
- Premature infants previously included in EPINUTRI study
- Non opposition of the parents for the collection of clinical and nutritional data
You may not qualify if:
- Refusal of the parents to collect clinical and nutritional data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hôpital Necker Assistance Publique- Hôpitaux de Paris
Paris, 75015, France
Related Publications (1)
Pierrat V, Marchand-Martin L, Marret S, Arnaud C, Benhammou V, Cambonie G, Debillon T, Dufourg MN, Gire C, Goffinet F, Kaminski M, Lapillonne A, Morgan AS, Roze JC, Twilhaar S, Charles MA, Ancel PY; EPIPAGE-2 writing group. Neurodevelopmental outcomes at age 5 among children born preterm: EPIPAGE-2 cohort study. BMJ. 2021 Apr 28;373:n741. doi: 10.1136/bmj.n741.
PMID: 33910920RESULT
Biospecimen
saliva, whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Lapillonne, M.D, Ph.D.
Hôpital Necker Assistance Publique-Hôpitaux de Paris
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 3, 2014
First Posted
July 9, 2014
Study Start
July 1, 2014
Primary Completion
July 1, 2015
Study Completion
December 31, 2017
Last Updated
November 20, 2025
Record last verified: 2025-09